Study: Antimalarial drug touted by Trump linked to increased risk of death in coronavirus patients

A study of 96,000 hospitalized coronavirus patients on six continents found that those who received an antimalarial drug promoted by President Donald Trump ... Read more

Bron:

SignOnSanDiego.com stories